Tell us what do you think about our website?

Trial Logo

WELCOME TO THE EMPOWER STUDY

EMPOWER: Early signs Monitoring to Prevent relapse in psychosis and prOmote Wellbeing, Engagement and Recovery (Phase 2)

What is EMPOWER?

EMPOWER is a three year feasibility study which will develop and test a mobile phone application (app) to enhance detection of Early Warning Signs of psychosis for people with a diagnosis of schizophrenia, their carers and mental health staff. Relapse in schizophrenia is a major cause of distress and disability but through regular monitoring of thoughts and feelings it is possible to identify early warning signs which can support earlier intervention and improved outcomes.

More information is available on the background to EMPOWER at the study website: https://empowerstudy.net

Through developing a stepped care model of intervention our goals are to:

•     Enhance self-management and empowerment for people in receipt of services.

•     Support detection of increased risk of relapse.
•     Improve the quality of information available on early warning signs.
•     Support relationships between people in receipt of services, their informal carers and mental health staff.

This mixed methods study has two phases. The first phase involves gathering views on the development and use of the App and the second is a cluster randomised controlled trial. The trial will randomise six community mental health teams in NHS Greater Glasgow and Clyde and two in Melbourne to either receive the App intervention or treatment as usual.
placeholder

Key contacts

Click on cards to find out more

Organisation

EMPOWER is funded by the UK National Institute of Health Research (NIHR) and Australian National Health Medical Research Council (NHMRC). The University of Glasgow are lead partners in this international collaboration along with Australian Catholic University and the University of Manchester.

General Data Protection Regulation (GDPR)
Participant Information

NHS Greater Glasgow & Clyde is the sponsor for this study based in the United Kingdom. We will be using information from you and your medical records in order to undertake this study and will act as the data controller for this study. This means that we are responsible for looking after your information and using it properly. NHS Greater Glasgow & Clyde will keep identifiable information about you [for one year after the study has finished].

Your rights to access, change or move your information are limited, as we need to manage your information in specific ways in order for the research to be reliable and accurate. If you withdraw from the study, we will keep the information about you that we have already obtained. To safeguard your rights, we will use the minimum personally-identifiable information possible.

You can find out more about how we use your information by contacting Professor Andrew Gumley (phone: 0141 330 4852 or email: andrew.gumley@glasgow.ac.uk).